Literature DB >> 16458253

Phage display selection of peptides that inhibit metastasis ability of gastric cancer cells with high liver-metastatic potential.

Shengjuan Hu1, Xinning Guo, Huahong Xie, Yulei Du, Yanglin Pan, Yongquan Shi, Jun Wang, Liu Hong, Shuang Han, Dongtao Zhang, Dawei Huang, Kedong Zhang, Feihu Bai, Haiping Jiang, Huihong Zhai, Yongzhan Nie, Kaichun Wu, Daiming Fan.   

Abstract

Organ-specific metastasis is an important character of cancer cells. Cancer cells that can metastasize to a special organ were thought to have different proteins in cell membrane, which might have potential utility as diagnostic markers and therapeutic targets. In the present work, based on high liver-metastatic gastric cancer cells, XGC9811-L, a screening approach with phage displayed peptide library, was successfully used to isolate 8-mer peptide ligands binding to the target cells. The phage20 had the highest binding efficiency to XGC9811-L cells, which also displayed remarkable cell specificity. Peptide20 that was displayed on phage20 could suppress the motility and invasion of XGC9811-L significantly. The adhesive ability of XGC9811-L to collagen IV was also inhibited by peptide20. Furthermore, phage20 could significantly reduce the incidence of liver metastasis of gastric cancer transplanted into nude mice and was also beneficial for the reduction the number of metastatic nodules in the liver. In conclusion, the phage display is an effective method to screen for the new molecules associated with organ-specific metastasis. The selected peptide20 can reverse the liver metastasis behavior of the gastric cancer cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16458253     DOI: 10.1016/j.bbrc.2006.01.047

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

Review 1.  Combinatorial peptide libraries: mining for cell-binding peptides.

Authors:  Bethany Powell Gray; Kathlynn C Brown
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

2.  Identification of a novel short peptide seal specific to CD59 and its effect on HeLa cell growth and apoptosis.

Authors:  Bing Li; Mei-Hua Gao; Xian-Ming Chu; Ying-Jie Xu; Fan Yang
Journal:  Cell Oncol (Dordr)       Date:  2012-09-04       Impact factor: 6.730

3.  Inhibitory effects of a specific phage-displayed peptide on high peritoneal metastasis of gastric cancer.

Authors:  Feihu Bai; Jie Liang; Jun Wang; Yongquan Shi; Kedong Zhang; Shuhui Liang; Liu Hong; Huihong Zhai; Yuanyuan Lu; Yu Han; Fang Yin; Kaichun Wu; Daiming Fan
Journal:  J Mol Med (Berl)       Date:  2006-10-17       Impact factor: 4.599

4.  TMTP1, a novel tumor-homing peptide, specifically targets hematological malignancies and their metastases.

Authors:  Min Xiao; Zhenya Hong; Lishi Sun; Ying Wu; Na Zhang; Yanan Liu; Danfeng Luo; Jianfeng Zhou; Chunrui Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-10-25

5.  Purification of a Pd20-TNFα fusion protein that prevents liver metastasis of gastric cancer.

Authors:  Sheng-Juan Hu; Rong-Xing Jiang; Hua-Hong Xie; Ai-Ling Ma; Hong-Li Shi; Hao Shen; Zhi-Ming Hao
Journal:  Tumour Biol       Date:  2014-05-02

6.  A novel melanoma-targeting peptide screened by phage display exhibits antitumor activity.

Authors:  Alisson L Matsuo; Aparecida S Tanaka; Maria A Juliano; Elaine G Rodrigues; Luiz R Travassos
Journal:  J Mol Med (Berl)       Date:  2010-08-28       Impact factor: 4.599

7.  Screening and identification of a targeting peptide to hepatocarcinoma from a phage display peptide library.

Authors:  Binghua Zhang; Yanqiong Zhang; Jiwei Wang; Yangde Zhang; Jiji Chen; Yifeng Pan; Lifeng Ren; Zhiyuan Hu; Jingfeng Zhao; Mingmei Liao; Shunwei Wang
Journal:  Mol Med       Date:  2007 May-Jun       Impact factor: 6.354

8.  p75 neurotrophin receptor suppresses the proliferation of human gastric cancer cells.

Authors:  Haifeng Jin; Yanglin Pan; Lina Zhao; Huihong Zhai; Xiaohua Li; Li Sun; Lijie He; Yu Chen; Liu Hong; Yulei Du; Daiming Fan
Journal:  Neoplasia       Date:  2007-06       Impact factor: 5.715

Review 9.  Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.

Authors:  Kathlynn C Brown
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

Review 10.  Targeting Tumors with Small Molecule Peptides.

Authors:  Andrew G Cheetham; Daniel Keith; Pengcheng Zhang; Ran Lin; Hao Su; Honggang Cui
Journal:  Curr Cancer Drug Targets       Date:  2016       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.